Corcept Therapeutics (CORT) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -148.75% |
| Dec 31, 2025 | -120.30% |
| Sep 30, 2025 | 97.68% |
| Jun 30, 2025 | 130.08% |
| Mar 31, 2025 | -330.90% |
| Dec 31, 2024 | -208.59% |
| Sep 30, 2024 | 138.59% |
| Jun 30, 2024 | -249.00% |
| Mar 31, 2024 | -39.30% |
| Dec 31, 2023 | 138.62% |
| Sep 30, 2023 | 52.51% |
| Jun 30, 2023 | -154.61% |
| Mar 31, 2023 | 1,352.28% |
| Dec 31, 2022 | 7.98% |
| Sep 30, 2022 | 156.18% |
| Jun 30, 2022 | -68.30% |
| Mar 31, 2022 | 7.71% |
| Dec 31, 2021 | -2,200.67% |
| Sep 30, 2021 | -101.72% |
| Jun 30, 2021 | 280.81% |
| Mar 31, 2021 | -152.18% |
| Dec 31, 2020 | 263.18% |
| Sep 30, 2020 | -7.74% |
| Jun 30, 2020 | -148.78% |
| Mar 31, 2020 | 488.98% |
| Dec 31, 2019 | -3.68% |
| Sep 30, 2019 | -255.38% |
| Jun 30, 2019 | 5.81% |
| Mar 31, 2019 | 3.80% |
| Dec 31, 2018 | 183.29% |
| Sep 30, 2018 | 239.52% |
| Jun 30, 2018 | -195.00% |
| Mar 31, 2018 | 102,850.00% |
| Dec 31, 2017 | 100.08% |
| Sep 30, 2017 | 41.12% |
| Jun 30, 2017 | 67.90% |
| Mar 31, 2017 | -469.38% |
| Dec 31, 2016 | -39.58% |
| Sep 30, 2016 | 481.44% |
| Jun 30, 2016 | 238.19% |
| Mar 31, 2016 | -92.25% |
| Dec 31, 2015 | 766.39% |
| Sep 30, 2015 | 33.92% |
| Jun 30, 2015 | -106.60% |
| Mar 31, 2015 | 641.27% |
| Dec 31, 2014 | 64.80% |
| Sep 30, 2014 | 25.40% |
| Jun 30, 2014 | 14.34% |
| Mar 31, 2014 | -35.68% |
| Dec 31, 2013 | 4.26% |
| Sep 30, 2013 | 6.20% |
| Jun 30, 2013 | 20.15% |
| Mar 31, 2013 | -34.62% |
| Dec 31, 2012 | -112.88% |
| Sep 30, 2012 | 963.47% |
| Jun 30, 2012 | -358.29% |
| Mar 31, 2012 | 147.88% |
| Dec 31, 2011 | 1.14% |
| Sep 30, 2011 | 9.32% |
| Jun 30, 2011 | -120.13% |
| Mar 31, 2011 | 887.24% |
| Dec 31, 2010 | 31.38% |